Nyxoah SA Ordinary Shares (NYXH) stock analysis and AI prediction
The company facts of Nyxoah SA Ordinary Shares, with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Nyxoah SA Ordinary Shares
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
- Exchange
- NASDAQ
- Market value
- $91.2 million
- Size
- Micro cap
- Employees
- 154
- Listed since
- March 5, 2021
- Website
- nyxoah.com
Related stocks
Other micro cap stocks
Keep going
NYXH questions
What is the AI prediction for NYXH stock?
Each market day our model rates Nyxoah SA Ordinary Shares (NYXH) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the NYXH prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for NYXH?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see NYXH options?
The NYXH options page opens its calls and puts, with price, volume, implied volatility and the Greeks.